Nano Nuclear Energy Inc.
NNENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NNE. That does not mean none is planned.
Get an email about NNE's next catalysts
Track Nano Nuclear Energy (NNE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
NNE Earnings Report
EPS Est: $-0.31 | FQ end Sep/2026 | Call: amc
Market Overview
Stock performance and key metrics
Nano Nuclear Energy is an American company focused on the development of nuclear microreactor technologies and related nuclear services, headquartered in New York City and Oak Ridge, Tennessee. The company is an official member of the United States Nuclear Industry Council (USNIC) and the Nuclear Institute based in the United Kingdom. It was selected as a founding member of the HALEU (High Assay Low Enriched Uranium) consortium of the United States Department of Energy.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Nano Nuclear Energy Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Nano Nuclear Energy Inc. (NNE) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track NNE biotech catalysts?β
Add NNE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Nano Nuclear Energy Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
